Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,590 | 7,721 | 4,252 | 6,089 | 26 |
| Receivables | 1,079 | 4,049 | N/A | N/A | N/A |
| Inventories | 22,660 | 22,639 | 22,287 | 17,209 | 15,339 |
| TOTAL | $31,686 | $37,945 | $27,935 | $24,611 | $18,375 |
| Non-Current Assets | |||||
| Investments And Advances | 38 | 38 | 38 | 38 | 38 |
| Intangibles | 9,347 | 9,347 | 9,347 | 9,347 | 9,347 |
| Other Non-Current Assets | 91,470 | 93,062 | 93,619 | 93,681 | 93,722 |
| TOTAL | $100,855 | $102,447 | $103,004 | $103,066 | $103,107 |
| Total Assets | $132,541 | $140,392 | $130,938 | $127,677 | $121,481 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,454 | 11,021 | 13,694 | 10,094 | 9,368 |
| Accrued Expenses | 27,740 | 7,788 | 7,483 | 12,234 | 11,963 |
| Other current liabilities | 17,650 | 18,250 | 22,650 | 28,400 | 28,400 |
| TOTAL | $55,016 | $38,207 | $44,915 | $51,843 | $49,877 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,515 | 1,855 | 1,509 | 1,181 | 1,382 |
| TOTAL | $8,441 | $8,717 | $8,496 | $8,274 | $8,029 |
| Total Liabilities | $63,456 | $46,924 | $53,410 | $60,116 | $57,906 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,453 | 22,376 | 20,763 | 17,012 | 10,290 |
| Common Shares | 22 | 22 | 18 | 15 | 9 |
| Retained earnings | -268,256 | -247,025 | -238,804 | -230,845 | -222,055 |
| Other shareholders' equity | 7,543 | 13,510 | 9,977 | 2,502 | 2,916 |
| TOTAL | $69,085 | $93,468 | $77,528 | $67,561 | $63,576 |
| Total Liabilities And Equity | $132,541 | $140,392 | $130,938 | $127,677 | $121,481 |